VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ENOV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ENOVEnovis Corporation
$22.02$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksENOVCash Flow

Enovis Corporation (ENOV) Cash Flow Statement

21Y historyFree accessUpdated daily

Free cash flow remains inconsistent and negative at -$28.9 million in 2026Q1, exacerbated by a capital-intensive profile where CapEx consistently consumes between 7% and 10% of revenue.

ENOV Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05
Cash from Operations242.84M217.29M113.5M134.99M-55.86M356.1M301.94M130.95M226.37M218.77M246.97M303.81M385.76M362.17M164.3M57.15M61.97M38.29M-31.51M74.48M-17.36M-7.75M
Operating CF Margin %-9.67%5.39%7.91%-3.57%24.97%26.94%3.94%6.17%6.63%6.77%7.66%8.34%8.61%4.2%8.24%11.43%7.29%-5.21%14.71%-4.41%-2.24%
Operating CF Growth %2169.67%91.44%-15.92%341.65%-115.69%17.94%130.58%-42.15%3.47%-11.42%-18.71%-21.24%6.51%120.43%187.47%-7.77%61.85%221.49%-142.31%529.17%-123.82%-
Net Income-1.14B-1.18B-824.82M-33.26M-11.76M76.28M45.77M-517.15M154.47M169.51M145.19M187.18M420.27M209.14M-42.26M4.55M16.21M21.72M-571K64.88M94K12.25M
Depreciation & Amortization297.05M294.38M284.8M217.1M219.71M262.92M246.23M236.03M141.88M134.75M143.26M154.54M174.72M119.26M200.4M22.6M16.13M15.07M14.79M16.88M13.14M12.91M
Stock-Based Compensation26.26M32.92M29.66M34.06M38.95M35.35M28.91M21.96M25.1M21.55M19.02M16.32M17.58M13.33M9.37M4.91M3.14M2.59M11.33M000
Deferred Taxes-19.65M-2.23M-10.02M-27.41M6.32M-22.19M-29.22M-590K-66.57M12.07M-1.68M-22.72M-139.49M9.95M7.22M-1.72M-296K3.59M-13.36M22.19M-6.21M-3.44M
Other Non-Cash Items1.03B1.06B647.81M-28.24M-88.59M20.84M5.25M522.15M4.82M-86.98M4.18M10.1M9.09M30.59M68.72M22.56M-518K613K-16.02M-35K1.05M-721K
Working Capital Changes27.33M15.46M-13.93M-27.27M-220.49M-17.1M4.99M-131.46M-33.33M-32.13M-62.99M-41.61M-96.42M-20.11M-10.43M4.25M27.3M-5.31M-27.68M-29.43M-25.43M-28.75M
Change in Receivables878K-10.75M-57.05M-16.32M-45.19M-110.98M42.69M49.92M-72.41M-44.34M-50.96M64.05M-19.92M-98.91M-37.34M-5.97M-6.06M16.28M-20.61M000
Change in Inventory-10.76M-11.98M39.07M-24.74M-118.79M-129.97M23.79M-44.89M-47.16M-34.02M19.66M-390K57.85M79.99M26.69M10.84M11.6M10.76M-15.56M-2.28M-12.47M-7.41M
Change in Payables21.56M-1.14M13.98M-6.64M-11.84M178.47M-30.75M-119.33M70.08M10.27M52.31M-11.18M-54.67M128.89M88.93M-10.9M-5.54M-28.46M7.02B000
Cash from Investing-171.95M-179.37M-955.47M-242.47M-176.39M-320.48M-175.08M-1.63B-167.85M89.88M-81.99M-246.96M-1.03B-474.97M-1.94B-69.97M-40.41M-12.05M-20.53M-46.52M-10.08M-18.43M
Capital Expenditures-200.37M-197.38M-180.71M-122.22M-105.45M-104.24M-114.78M-125.4M-69.65M-68.77M-63.25M-69.88M-81.34M-71.48M-83.59M-14.79M-12.53M-11.01M-20.11M-13.67M-10.24M-7.08M
CapEx % of Revenue8.79%8.78%8.57%7.16%6.75%7.31%10.24%3.77%1.9%2.08%1.73%1.76%1.76%1.7%2.14%2.13%2.31%2.1%3.33%2.7%2.6%2.05%
Acquisitions-21.8M16.4M-769.91M-152.81M-73.68M-223.27M-69.85M-1.52B-272.51M143.54M-25.99M-196.01M-948.8M-372.48M-1.86B-56.35M-27.96M-1.26M-439K-32.99M0-14.72M
Investments----------------------
Other Investing50.22M1.6M-4.84M32.57M2.75M7.03M9.55M7.78M34.83M15.1M7.25M18.93M3.12M-31.01M2.26M1.16M74K219K23K133K157K3.37M
Cash from Financing-77.57M-52.4M846.82M127.8M-465.13M584.91M-131.65M1.37B-47.15M-280.45M-145.22M-131.27M650.05M-45.05M2.19B32.74M-8.04M-5.42M34.84M11.74M26.56M-65.9M
Debt Issued (Net)-72.43M-43.6M859.23M217.19M-1.59B-150.41M-118.32M1.11B158.24M-277.38M-118.78M-88.89M90.94M-309.03M1.15B29.02M-8.96M-5.42M-113.91M11.74M26.56M34.84M
Equity Issued (Net)1.6M1.32M-2.9M1.78M5.81M745.18M3.5M11.88M-200M6.94M-20.81M-27.37M594.36M324.15M1.09B3.72M912K0187.29M00-82M
Dividends Paid000000000000-3.85M-20.4M-17.45M00-38.55B-38.55M00-18.74M
Share Repurchases00-4.77M00000-200M0-20.81M-27.37M00000-5.73B-5.73M00-82M
Other Financing-6.75M-10.12M-9.51M-91.17M1.12B-9.87M-16.84M248.83M-5.39M-10.01M-5.62M-15.01M-31.4M-39.78M-29.29M0000000
Net Change in Cash-5.33M-11.78M3.33M20.54M-695.08M618.3M-8.56M-135.39M-17M40.29M24.26M-107.98M-5.85M-171.15M407.34M14.57M10.58M21.2M-19.33M40.48M-213K-92.4M
Free Cash Flow35.92M19.92M-67.21M12.77M-161.31M251.86M187.15M5.55M156.72M150M183.72M233.94M304.42M290.69M80.71M42.37M49.44M27.28M-51.63M60.81M-27.59M-14.84M
FCF Margin %1.58%0.89%-3.19%0.75%-10.32%17.66%16.7%0.17%4.27%4.55%5.04%5.9%6.58%6.91%2.06%6.11%9.12%5.2%-8.54%12.01%-7.01%-4.29%
FCF Growth %192.15%129.63%-626.52%107.91%-164.05%34.58%3274.5%-96.46%4.48%-18.35%-21.46%-23.15%4.72%260.15%90.51%-14.3%81.22%152.84%-184.89%320.41%-85.99%-
FCF per Share0.630.35-1.220.23-2.984.924.040.123.893.634.475.627.368.602.672.873.381.88-4.618.34-3.78-2.03
FCF Conversion (FCF/Net Income)-0.03x-0.18x-0.14x-4.06x4.20x4.97x7.08x-0.25x1.61x1.45x1.93x1.81x0.98x2.03x-2.55x12.55x3.82x1.76x55.19x1.15x-184.63x-0.63x
Interest Paid0051.83M16.33M37.09M85.49M104.62M139.27M50.39M43.5M35.84M36.36M42.04M58.97M79.86M-5.21M6.11M6.62M9.97M000
Taxes Paid0010.8M12.52M31.36M47.19M59.38M134.91M97.45M70.67M77.1M79.54M82.69M93.86M70.68M-16.73M5.82M16.6M18.53M000

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Persistent negative net margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Amortization

As reported in recent financial statements, Enovis exhibits a significant disconnect between GAAP net income and operating cash flow, with the latter consistently remaining positive despite deep net losses, suggesting that non-cash charges like amortization are the primary drivers of the reported bottom-line deficits.

The persistent gap between net income and operating cash flow indicates that the company's cash-generative capacity is significantly healthier than the headline net loss figures suggest. Investors should monitor whether this cash flow stability persists as integration-related non-cash charges eventually normalize over the coming fiscal periods.

Free Cash Flow Volatility Persists

Based on quarterly cash flow data, Enovis's free cash flow trajectory remains highly inconsistent, oscillating between positive and negative territory, with a recent FCF margin of -4.9% in 2026Q1 highlighting the ongoing difficulty in balancing aggressive growth investments with core operational cash generation.

The inability to maintain a positive FCF trajectory suggests that the company is still in a heavy investment phase, likely tied to the integration of recent acquisitions. This volatility warrants further investigation into whether the business can achieve sustainable self-funding status without further reliance on external capital.

Capital Intensity Remains Elevated

According to historical filings, Enovis maintains a capital-intensive profile with CapEx as a percentage of revenue consistently hovering between 7% and 10%, reflecting the substantial investment required to support its specialized surgical instrumentation and the ongoing expansion of its reconstructive implant product lines.

This level of capital intensity appears necessary to maintain competitive parity in the reconstructive market, but it places a structural drag on free cash flow. Analysts should evaluate if these expenditures are effectively driving the intended market share gains or if they represent a permanent, high-cost maintenance requirement.

Working Capital Fluctuations Impact Liquidity

As indicated by recent cash flow statements, Enovis experiences significant working capital volatility, with quarterly changes ranging from a $60.3 million outflow in 2024Q1 to a $40.3 million inflow in 2024Q4, suggesting that inventory management and collection cycles remain sensitive to operational integration efforts.

The erratic nature of these working capital swings may imply challenges in synchronizing supply chain logistics with the company's rapid portfolio expansion. Investors should monitor whether these fluctuations stabilize as the company moves past the most intensive phases of its post-spin-off and acquisition integration.

ENOV — Frequently Asked Questions

Quick answers to the most common questions about buying ENOV stock.

How much cash does Enovis Corporation (ENOV) generate from operations?

Enovis Corporation (ENOV) generated $217.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Enovis Corporation's free cash flow?

Enovis Corporation (ENOV) generated $19.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Enovis Corporation's capital expenditure (CapEx)?

Enovis Corporation (ENOV) spent $197.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.